These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38908100)

  • 1. The neurophysiological brain-fingerprint of Parkinson's disease.
    da Silva Castanheira J; Wiesman AI; Hansen JY; Misic B; Baillet S; ;
    EBioMedicine; 2024 Jul; 105():105201. PubMed ID: 38908100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurophysiological brain-fingerprint of Parkinson's disease.
    da Silva Castanheira J; Wiesman AI; Hansen JY; Misic B; Baillet S; ;
    medRxiv; 2023 Dec; ():. PubMed ID: 36798232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cortical signature of symptom laterality in Parkinson's disease.
    Heinrichs-Graham E; Santamaria PM; Gendelman HE; Wilson TW
    Neuroimage Clin; 2017; 14():433-440. PubMed ID: 28271041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.
    Gustavsson EK; Follett J; Trinh J; Barodia SK; Real R; Liu Z; Grant-Peters M; Fox JD; Appel-Cresswell S; Stoessl AJ; Rajput A; Rajput AH; Auer R; Tilney R; Sturm M; Haack TB; Lesage S; Tesson C; Brice A; Vilariño-Güell C; Ryten M; Goldberg MS; West AB; Hu MT; Morris HR; Sharma M; Gan-Or Z; Samanci B; Lis P; Periñan MT; Amouri R; Ben Sassi S; Hentati F; ; Tonelli F; Alessi DR; Farrer MJ
    Lancet Neurol; 2024 Jun; 23(6):603-614. PubMed ID: 38614108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebello-cortical network fingerprints differ between essential, Parkinson's and mimicked tremors.
    Muthuraman M; Raethjen J; Koirala N; Anwar AR; Mideksa KG; Elble R; Groppa S; Deuschl G
    Brain; 2018 Jun; 141(6):1770-1781. PubMed ID: 29701820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
    Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
    Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
    Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
    Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse and compensatory neurophysiological slowing in Parkinson's disease.
    Wiesman AI; da Silva Castanheira J; Degroot C; Fon EA; Baillet S; ; Network QP
    Prog Neurobiol; 2023 Dec; 231():102538. PubMed ID: 37832713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
    Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
    Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-stimulus beta power modulation during motor sequence learning is reduced in 'Parkinson's disease.
    Meissner SN; Krause V; Südmeyer M; Hartmann CJ; Pollok B
    Neuroimage Clin; 2019; 24():102057. PubMed ID: 31715558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling Parkinson's disease cognitive phenotypes via resting-state magnetoencephalography.
    Simon OB; Rojas DC; Ghosh D; Yang X; Rogers SE; Martin CS; Holden SK; Kluger BM; Buard I
    J Neurophysiol; 2022 Jan; 127(1):279-289. PubMed ID: 34936515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of brain oscillations in motor sequence learning: Insights from Parkinson's disease.
    Meissner SN; Krause V; Südmeyer M; Hartmann CJ; Pollok B
    Neuroimage Clin; 2018; 20():448-457. PubMed ID: 30128283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive decline in Parkinson's disease is associated with slowing of resting-state brain activity: a longitudinal study.
    Olde Dubbelink KT; Stoffers D; Deijen JB; Twisk JW; Stam CJ; Berendse HW
    Neurobiol Aging; 2013 Feb; 34(2):408-18. PubMed ID: 22495052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional brain imaging: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(22):1-79. PubMed ID: 23074493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease.
    Heinrichs-Graham E; Wilson TW; Santamaria PM; Heithoff SK; Torres-Russotto D; Hutter-Saunders JA; Estes KA; Meza JL; Mosley RL; Gendelman HE
    Cereb Cortex; 2014 Oct; 24(10):2669-78. PubMed ID: 23645717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auditory entrainment of motor responses in older adults with and without Parkinson's disease: An MEG study.
    Buard I; Dewispelaere WB; Teale P; Rojas DC; Kronberg E; Thaut MH; Kluger BM
    Neurosci Lett; 2019 Aug; 708():134331. PubMed ID: 31226362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise- and strategy-based physiotherapy-delivered intervention for preventing repeat falls in people with Parkinson's: the PDSAFE RCT.
    Ashburn A; Pickering R; McIntosh E; Hulbert S; Rochester L; Roberts HC; Nieuwboer A; Kunkel D; Goodwin VA; Lamb SE; Ballinger C; Seymour KC
    Health Technol Assess; 2019 Jul; 23(36):1-150. PubMed ID: 31339100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
    Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.